6-acetylaminocaproic acid has been researched along with Rheumatic Diseases in 1 studies
6-acetylaminocaproic acid: wound-healing agent component of plasmutan
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez de la Serna, A | 1 |
| Díaz-Rubio, M | 1 |
1 trial available for 6-acetylaminocaproic acid and Rheumatic Diseases
| Article | Year |
|---|---|
Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
Topics: Adult; Aged; Aminocaproates; Aminocaproic Acid; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 1994 |